hallucinogen
Our editors will review what you’ve submitted and determine whether to revise the article.
- National Institute of Drug Abuse - Hallucinogen
- National Institute on Drug Abuse - What are hallucinogens?
- Verywell Mind - Types of Hallucinogens and How They Work
- National Center for Biotechnology Information - PubMed Central - The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges
- Key People:
- Timothy Leary
- Ram Dass
- Related Topics:
- LSD
- ketamine
- Ecstasy
- diviner’s sage
- PCP
hallucinogen, substance that produces psychological effects that tend to be associated with phenomena such as dreams or religious exaltation or with mental disorders such as schizophrenia. Hallucinogens produce changes in perception, thought, and feeling, ranging from distortions of what is sensed (illusions) to sensing objects where none exist (hallucinations). Hallucinogens heighten sensory signals, but this is often accompanied by loss of control over what is experienced.
Psychopharmacological drugs
The psychopharmacological drugs that have aroused widespread interest and controversy are those that produce marked aberrations in behaviour or perception. Among the most prevalent of these are d-lysergic acid diethylamide, or LSD-25, which originally was derived from ergot (Claviceps purpurea), a fungus on rye and wheat; mescaline, the active principle of the peyote cactus (Lophophora williamsii), which grows in the southwestern United States and Mexico; and psilocybin and psilocin, which come from certain mushrooms (notably two Mexican species, Psilocybe mexicana and P. cubensis).
Other hallucinogens include bufotenine, originally isolated from the skin of toads; harmine, from the seed coats of a plant of the Middle East and Mediterranean region; and the synthetic compounds methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA), and phencyclidine (PCP). Tetrahydrocannabinol (THC), the active ingredient in cannabis, or marijuana, obtained from the leaves and tops of plants in the genus Cannabis, is also sometimes classified as a hallucinogen.
Historical use and early scientific interest
Historically, native societies of the Western Hemisphere utilized plants containing psychedelic substances. The hallucinogenic mushrooms of Mexico were considered sacred and were called “god’s flesh” by the Aztecs, and during the 19th century the Mescalero Apaches of the southwestern United States practiced a peyote rite that was adopted by many of the Plains tribes. Peyotism eventually became fused with Christianity, and the Native American Church was formed in 1918 to protect peyotism as a form of worship.
Scientific interest in hallucinogens developed slowly. Mescaline was finally isolated as the active principle of peyote in 1896. It was not until 1943, when Swiss chemist Albert Hofmann accidentally ingested a synthetic preparation of LSD and experienced its psychedelic effects, that the search for a natural substance responsible for schizophrenia became widespread. Gordon Wasson, a New York banker and mycologist, called attention to the powers of the Mexican mushrooms in 1953, and the active principle was quickly found to be psilocybin.
Only the d-isomer of LSD was found to be psychedelically active. It was thought that LSD, as well as psilocybin, psilocin, bufotenine, and harmine, acted antagonistically toward serotonin, an important brain amine. However, evidence for this was contradictory. Some chemicals that blocked serotonin receptors in the brain were found to have no psychedelic activity. Mescaline was discovered to be structurally related to the adrenal hormones epinephrine and norepinephrine—catecholamines that are very active in the peripheral nervous system and are suspected of playing a role as neurotransmitters in the central nervous system.
Psychotherapy and illicit use
During the 1950s and ’60s there was a great deal of scientific research with hallucinogens in psychotherapy. LSD was used in the treatment of alcoholism, to reduce the suffering of terminally ill cancer patients, and in the treatment of children with autism. Controversy arose over the social aspects of the drugs. Subsequent scientific research indicated that the side effects of these drugs were more serious than previous research had indicated and that human experimentation was somewhat premature. As a result, many of the hallucinogens were limited to scientific use, with pharmaceutical manufacture strictly regulated.
Illicit experimentation continued over the following decades, partly inspired by the mystical writings of Aldous Huxley, and a vigorous subculture sprang up surrounding hallucinogens in the 1960s. Originating on the West Coast of the United States, it spread throughout North America, Western Europe, and Australia. At the end of the century there was a revived interest in LSD in the United States, and the drug Ecstasy became popular among young people. In addition, some individuals began experimenting with countless new substances, particularly from the phenethylamine and tryptamine families, which was difficult to regulate or suppress because the necessary information to make the drugs was widely available through the internet.
John Philip Jenkins